InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.

Arsenal Medical develops innovative biomaterials to solve challenging and underserved medical problems. Our lead products target neurovascular and trauma conditions providing control of blood flow to tumors and bleeding conditions, such as hemorrhage.  Visit website.

SamanTree Medical's Histolog Scanner is a digital microscopy scanner for high-resolution imaging of the surface of fresh tissue. The device utilizes novel, ultra-fast confocal microscopy technology to enable rapid histological assessment in the operating room or pathology laboratory.  Visit website.

Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.  Visit website.

Axena Health is dedicated to improving the lives of women with pelvic floor disorders. The company's Leva Pelvic Health system helps women train and strengthen their pelvic floor muscles from their homes to improve the management of stress, mixed, and mild-to-moderate urinary incontinence and chronic fecal incontinence.  Visit website.

iO Urology aims to improve the lives of people living with urologic conditions. The company’s CarePath device is a remote patient monitoring system to promote urologic care at home. CarePath provides real-time, quantitative measurement of urinary output and flow to support the management of lower urinary tract symptoms from conditions such and benign prostatic hypertrophy and overactive bladder.  Visit website.

Prevencio develops personalized blood tests designed to improve the early detection and prevention of cardiovascular disease. Using machine learning, multi-proteomic biomarkers, and proprietary algorithms, Prevencio’s technology aims to provide more accurate diagnostic and prognostic insights than traditional methods. The company's patented tests have been published in leading cardiology journals and presented at major cardiovascular conferences. Prevencio’s approach is intended to reduce unnecessary procedures and improve patient outcomes. Visit website.

FundamentalVR offers an Immersive VR platform for specialty suite procedures and is a strategic partner helping med-device leaders to solve the Competency at Scale Gap. Through its purpose-built immersive VR platform, FundamentalVR provides high-fidelity VR, including unique HapticVR capabilities, for the precision of specialty surgeries, as well as behavioral telemetry and assessment data for AI/ML-driven insights.  Visit website.

Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration. Visit website.

Autonomix (Nasdaq: AMIX) is a medical device company developing a minimally invasive nerve-sensing, ablation, and verification system to advance the diagnosis and treatment of diseases involving the nervous system. The company’s catheter-based microchip sensing array is designed to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than existing technologies. This platform enables transvascular diagnosis and treatment of conditions affecting the peripheral nervous system. Initially focused on pancreatic cancer pain, Autonomix’s technology has potential applications across multiple fields, including cardiology, renal denervation, and chronic pain management. Visit website.

Flow Medical is developing a novel thrombolytic catheter for the treatment of pulmonary embolism. The device will combine imaging, infusion, and monitoring into a single solution to streamline procedures, improve therapeutic efficacy, and reduce inventory needs. Visit website.

Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries. Visit website.

THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant. Visit website.

Clairity develops AI-driven tools to enhance breast cancer screening and risk assessment. Its platform utilizes deep learning models to analyze mammographic images, aiming to improve early detection, reduce racial and ethnic biases, and personalize care plans. The technology is grounded in decades of research led by Dr. Connie Lehman at institutions such as Mass General Brigham and MIT. Clairity's approach seeks to transform mammography from a one-size-fits-all model to a precision medicine framework. Visit website.

URO-1is an emerging medtech company developing proprietary surgical solutions for office-based urology. The company is targeting the challenges associated with inadequate biopsy, which can lead to increased costs, procedure duplication, and diagnostic delay. The SUREcore and coreCARE platforms are two solutions within the company’s portfolio that are intended to improve the standard of care in prostate biopsy and other soft tissue biopsy procedures. Visit website.

Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. Visit website.

28% of adults in the United States reported having chronic low back pain, yet current surgical treatments have unacceptably low success rates. Aposture Surgical has developed and clinically proven two radically different solutions to break this cycle of failure: an ultra-minimally invasive treatment for lumbar spinal stenosis and a novel fixation system for spinal fusion. Moreover, Aposture Surgical seeks to transform spinal surgery with its AI-enabled navigation system and robotic surgery platform to guide its surgical procedures. Visit website.

Anaut is a Tokyo-based technology company that is passionate about using the power of AI to drive innovation in the healthcare industry. Our mission is to revolutionize surgery by developing AI precision mapping technology that can improve surgical outcomes and reduce the risk of complications. Our flagship product, Surgical Vision EUREKA, is a game-changing solution that has been specifically designed to support this mission. EUREKA uses cutting-edge algorithms and deep learning methodologies to achieve real-time precision mapping of the surgical field, allowing surgeons to navigate through complex anatomical structures with greater precision and accuracy. By leveraging the power of AI, we believe that we can transform the surgical landscape and provide better outcomes for patients around the world. Visit website.

CygnusMed is advancing endovascular care with a novel hemostatic valve designed to provide continuous, uninterrupted sealing of the guiding catheter during interventions. The device enables arterial blood pressure monitoring without the need for a second arterial line, minimizes blood loss, and supports continuous saline flushing of the catheter to significantly reduce the risk of iatrogenic emboli. By addressing critical challenges in endovascular procedures, CygnusMed's innovative solution enhances safety, efficiency, and patient outcomes. Visit website.

Rekovar develops wearable biosensor technology aimed at improving the management of Neonatal Abstinence Syndrome (NAS). Its flagship product, NeoMonki, is an investigational neonatal monitoring kit designed to provide real-time, objective data on infants' physiological and behavioral states. The system includes a wristband sensor, imaging camera, tablet application, and a provider portal, enabling healthcare professionals to deliver personalized care and intervention. Visit website.

Nitinotes develops the EndoZip™, the first fully automated endoscopic suturing system for Endoscopic Sleeve Gastroplasty (ESG), a minimally invasive weight-loss procedure. Designed for efficiency, EndoZip enables a single-operator ESG procedure with automated, standardized suturing, reducing variability, procedure time, and training requirements. The system facilitates outpatient treatment with low-risk and predictable outcomes, addressing the growing need for effective, non-surgical obesity interventions. Visit website.

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

Osheru has developed innovative technology using compression skin contouring to remove excess unwanted skin. Our first product, the Ziplyft, makes an eyelid lift minimally invasive and easier on the surgeon and the patient, increasing efficiency by eliminating the need for cautery and suturing. With Ziplyft, surgeons can offer a premium experience to their patients and patients benefit with a natural refreshed look with improved symmetry, reduced downtime, and faster recovery than traditional blepharoplasty. At Osheru we are ‘Opening Eyes Beautifully'. Visit website.

EndoInnovate is developing a new oral colonoscopy preparation designed to improve the detection of subtle polyps and enhance colon cancer prevention. The product has shown promising results in human pilot studies and follows a strategic FDA 505(b)(2) regulatory pathway. With strong intellectual property protection and significant market potential, EndoInnovate is seeking seed funding to advance this technology and improve patient outcomes in colorectal cancer screening. Visit website.